Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist

Trends in Pharmacological Sciences - Tập 18 - Trang 186-188 - 1997
L.J. Bristow1, M.S. Kramer2, J. Kulagowski3, S. Patel4, C.I. Ragan1, G.R. Seabrook1
1Department of Pharmacology, Merck, Sharp and Dohme, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, UK CM20 2QR,
2Merck Research Laboratories, West Point, Philadelphia, PA, USA,
3Department of Medicinal Chemistry, Merck, Sharp and Dohme, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, UK CM20 2QR.
4Department of Biochemistry, Merck, Sharp and Dohme, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, UK CM20 2QR.

Tài liệu tham khảo

Van Tol, 1991, Nature, 350, 610, 10.1038/350610a0 O'Malley, 1992, The New Biologist, 4(2), 137 Seeman, 1993, Nature, 365, 441, 10.1038/365441a0 Reynolds, 1994, J. Neurochem., 63, 1576, 10.1046/j.1471-4159.1994.63041576.x McAllister, 1995, J. Recept. Signal Trans. Res., 15, 267, 10.3109/10799899509045220 Kulagowski, 1996, J. Med. Chem., 39, 1941, 10.1021/jm9600712 Seabrook, 1994, Br. J. Pharmacol., 112, 728, 10.1111/j.1476-5381.1994.tb13138.x Bowery, 1994, Br. J. Pharmacol., 112, 873, 10.1111/j.1476-5381.1994.tb13161.x Patel, 1996, Br. J. Pharmacol., 119, 30P Bristow, 1996, Br. J. Pharmacol., 119, 210P Kramer, M. S., Last, B., Getson, A. and Reines, S. A. Arch. Gen. Psychiatry in press